DAS181 Mechanism of Action

Ansun Biopharma

DAS181 is a novel host-directed recombinant fusion protein that has the potential to treat not just every strain of the Flu virus, including every pandemic strain, but every strain of every virus that uses sialic acid to infect people.

For more information, visit: www.ansunbiopharma.com

I really enjoyed working with Mark and his team at Amerra. Their approach to animation is very streamlined and well-organized, and they are great at keeping everyone moving forward on the project, including the client! The final work product speaks for itself, but the process of getting there is just as important, and the Amerra team excels in that aspect.

Mike HavluciyanChief Legal Officer